InsidersTradesSigma
Australian Clinical Labs Limited Stock: price and management transactions · Australia · ASX
Follow the Australian Clinical Labs Limited share price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Operating in the Health Care sector, Australian Clinical Labs Limited has published 5 public disclosures. Market capitalisation: €408.5m. The latest transaction was filed on 20 May 2026 (Change in Substantial Holding). Among the most active insiders: its controlled bodies corporate listed in Annexure A. The full history is accessible without an account.
5
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Australian Clinical Labs Limited Buy (bullish), based on 8 analysts. Average price target: A$2.58.
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 995 of 25,564 companies
80.5
score / 100
Value91
Quality70
FCF yld42%
Earn yld7.8%
EV/EBITDA3.8x
ROE17%
Gross mgn83%
Net mgn4.4%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 May 2026
Declarations5 total
●
Substantial HolderExecutives(filed)
ShareASXASX:2924-03092202-3A693702
ShareASXASX:2924-03092061-3A693677
ShareASXASX:2924-03086307-3A692634
ShareASXASX:2924-03082737-3A692020
5 of 5 declarations